NO20011763L - Middel som forsinker transformasjon av hormonavhengig kreft til hormonuavhengig kreft - Google Patents

Middel som forsinker transformasjon av hormonavhengig kreft til hormonuavhengig kreft

Info

Publication number
NO20011763L
NO20011763L NO20011763A NO20011763A NO20011763L NO 20011763 L NO20011763 L NO 20011763L NO 20011763 A NO20011763 A NO 20011763A NO 20011763 A NO20011763 A NO 20011763A NO 20011763 L NO20011763 L NO 20011763L
Authority
NO
Norway
Prior art keywords
hormone
dependent cancer
delays
transformation
drug
Prior art date
Application number
NO20011763A
Other languages
English (en)
Other versions
NO20011763D0 (no
Inventor
Etsuya Matsutani
Kenichiro Naito
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20011763D0 publication Critical patent/NO20011763D0/no
Publication of NO20011763L publication Critical patent/NO20011763L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20011763A 1998-10-08 2001-04-06 Middel som forsinker transformasjon av hormonavhengig kreft til hormonuavhengig kreft NO20011763L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28679398 1998-10-08
PCT/JP1999/005533 WO2000020034A1 (fr) 1998-10-08 1999-10-07 Agents destines a retarder le passage d'un cancer hormono-dependant a un cancer hormono-independant

Publications (2)

Publication Number Publication Date
NO20011763D0 NO20011763D0 (no) 2001-04-06
NO20011763L true NO20011763L (no) 2001-06-07

Family

ID=17709122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011763A NO20011763L (no) 1998-10-08 2001-04-06 Middel som forsinker transformasjon av hormonavhengig kreft til hormonuavhengig kreft

Country Status (9)

Country Link
US (1) US20060135435A1 (no)
EP (1) EP1136079A4 (no)
KR (1) KR20010080007A (no)
CN (1) CN1322139A (no)
AU (1) AU6004999A (no)
CA (1) CA2345213A1 (no)
HU (1) HUP0103761A3 (no)
NO (1) NO20011763L (no)
WO (1) WO2000020034A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1382350A4 (en) * 2001-04-25 2006-01-04 Takeda Pharmaceutical MEANS AGAINST THE PROPHYLAXIS BEFORE POSTOPERATIVE REPEAT OF PREMOPEOPAUSAL BREAST CANCER
WO2002087618A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
WO2002087619A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
US7812044B2 (en) 2001-11-13 2010-10-12 Takeda Pharmaceutical Company Limited Anticancer agents
WO2003075958A1 (fr) 2002-03-11 2003-09-18 Takeda Chemical Industries, Ltd. Medicaments permettant de traiter une maladie dependant d'une hormone sexuelle
BR0313405A (pt) 2002-08-12 2005-07-12 Takeda Pharmaceutical Compostos, métodos para preparar um composto e para prevenir e/ou tratar câncer, prodroga, medicamento, modulador do receptor de androgênio, agente para prevenir e/ou tratar hipogonadismo ou pertubação climatérica masculina, osteoporose e câncer, e, uso de um composto
US8497691B2 (en) 2007-06-28 2013-07-30 Frymaster L.L.C. Oil quality sensor and adapter for deep fryers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
WO1989006692A1 (en) * 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
DE69736642T2 (de) * 1996-07-19 2007-09-20 Takeda Pharmaceutical Co. Ltd. Heterocyclische Verbindungen, ihre Herstellung und Verwendung
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
UA61970C2 (en) * 1997-08-15 2003-12-15 Combined use of tyrosine kinase inhibitor and a chemical castration agent for treating prostate cancer
PE20011178A1 (es) * 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion

Also Published As

Publication number Publication date
HUP0103761A2 (hu) 2002-02-28
WO2000020034A1 (fr) 2000-04-13
AU6004999A (en) 2000-04-26
NO20011763D0 (no) 2001-04-06
HUP0103761A3 (en) 2002-11-28
CA2345213A1 (en) 2000-04-13
KR20010080007A (ko) 2001-08-22
US20060135435A1 (en) 2006-06-22
EP1136079A4 (en) 2004-09-22
CN1322139A (zh) 2001-11-14
EP1136079A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
NO20032446L (no) System for blanding av fluider
DE60208726D1 (de) FM-CW-Radarsystem
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
IS2468B (is) Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini
NO20022866D0 (no) N¶ringsmiddelblanding, fremgangsmåte for fremstilling av nevnte blanding og anvendelser derav
IS2261B (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
MA24417A1 (fr) Comprime detrgent enrobe
DK1275397T3 (da) Lægemiddel til lokal anvendelse
ID23735A (id) Tablet trovafloksasin mesilat
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
DE69827484D1 (de) Stabilisierte tibolone zubereitungen
NO20011763L (no) Middel som forsinker transformasjon av hormonavhengig kreft til hormonuavhengig kreft
NO20013837D0 (no) Skjerm for stralingsbrenner
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
DK1239862T3 (da) Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft
PT1263421E (pt) Avasimibe, o inibidor duplo da sintese de ester de colesterilo e de ester ceroso, para o tratamento de disturbios da glandula sebacea
MA26604A1 (fr) Compositions pharmaceutiques.
NO20004044L (no) Streptomyces Avertimilis gen som styrer forholdet av B2:B1 avermectiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application